Clinical Implication of Dosimetry Formalisms for Electronic Low-Energy Photon Intraoperative Radiation Therapy.


Journal

Practical radiation oncology
ISSN: 1879-8519
Titre abrégé: Pract Radiat Oncol
Pays: United States
ID NLM: 101558279

Informations de publication

Date de publication:
Historique:
received: 24 10 2019
revised: 27 05 2020
accepted: 27 07 2020
pubmed: 17 8 2020
medline: 20 8 2021
entrez: 16 8 2020
Statut: ppublish

Résumé

Intraoperative radiation therapy (IORT) using the INTRABEAM, a miniature x-ray source, has shown to be effective in treating breast cancer. However, recent investigations have suggested a significant deviation between the reported and delivered doses. In this work, the dose delivered by INTRABEAM in the TARGIT breast protocol was investigated, along with the dose from the Xoft Axxent, another source used in breast IORT. The absorbed dose from the INTRABEAM was determined from ionization chamber measurements using: (a) the manufacturer-recommended formula (Zeiss V4.0 method), (b) a Monte Carlo calculated chamber conversion factor (C For a nominal TARGIT prescription of 20 Gy, the dose at the INTRABEAM applicator surface ranged from 25.2 to 31.7 Gy according to the C The doses delivered in the TARGIT breast protocol with INTRABEAM were significantly greater than the prescribed 20 Gy and depended on the size of spherical applicator used. Breast IORT treatments with the Xoft Axxent received less dose compared with TARGIT INTRABEAM, which could have implications for studies comparing clinical outcomes between the 2 devices.

Identifiants

pubmed: 32795615
pii: S1879-8500(20)30198-3
doi: 10.1016/j.prro.2020.07.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e114-e121

Informations de copyright

Copyright © 2020 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Auteurs

Peter G F Watson (PGF)

Medical Physics Unit, McGill University, Montreal, QC, Canada. Electronic address: peter.watson@mcgill.ca.

Marija Popovic (M)

Medical Physics Unit, McGill University, Montreal, QC, Canada.

Liheng Liang (L)

Medical Physics Unit, Department of Radiation Oncology, SMBD Jewish General Hospital, McGill University, Montreal, QC, Canada.

Nada Tomic (N)

Medical Physics Unit, Department of Radiation Oncology, SMBD Jewish General Hospital, McGill University, Montreal, QC, Canada.

Slobodan Devic (S)

Medical Physics Unit, Department of Radiation Oncology, SMBD Jewish General Hospital, McGill University, Montreal, QC, Canada.

Jan Seuntjens (J)

Medical Physics Unit, McGill University, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH